Paul Esteso, MD, PhD
Medical Co-Director, Cardiac Antithrombosis Management Program (CAMP); Physician Lead, Neuromuscular Cardiology Program; Associate Cardiologist, Department of Cardiology
Assistant Professor of Pediatrics, Harvard Medical School
Image
Paul Esteso, MD, PhD
Medical Co-Director, Cardiac Antithrombosis Management Program (CAMP); Physician Lead, Neuromuscular Cardiology Program; Associate Cardiologist, Department of Cardiology
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
Spanish
English
Publications
Ventricular Assist Device Use in Pediatric Restrictive and Hypertrophic Cardiomyopathy: An ACTION Registry Analysis. View Abstract
Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients. View Abstract
Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee. View Abstract
Taking ACTION to detect myocarditis related to recombinant gene transfer therapy for Duchenne Muscular Dystrophy; Consensus recommendations for cardiac surveillance. View Abstract
Real-World Use and Outcomes of Apixaban for Early Post-Surgical Fontan Thromboprophylaxis. View Abstract
Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology. View Abstract
Impact of a positive crossmatch on pediatric heart transplant outcomes. View Abstract
Contemporary Outcomes of Children With Acute Fulminant Myocarditis Supported With Peripheral Extracorporeal Membrane Oxygenation. View Abstract
Use of apixaban in children awaiting heart transplantation. View Abstract
Contemporary outcomes of pediatric cardiac transplantation with a positive retrospective crossmatch. View Abstract
Nucleated Red Blood Cells Are Predictive of In-Hospital Mortality for Pediatric Patients. View Abstract
Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease. View Abstract
Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. View Abstract
Initial multicenter experience with ventricular assist devices in children and young adults with muscular dystrophy: An ACTION registry analysis. View Abstract
The Surprise Question as a Trigger for Primary Palliative Care Interventions for Children with Advanced Heart Disease. View Abstract
Pneumatosis intestinalis after thoracic organ transplantation in children: A case series and review of the literature. View Abstract
Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. View Abstract
Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION. View Abstract
Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. View Abstract
Rehabilitation in Pediatric Heart Failure and Heart Transplant. View Abstract
The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2). View Abstract
Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. View Abstract
The use of human embryonic stem cells in drug discovery. Counterpoint. View Abstract
Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. View Abstract
Correction of moderate myopia is associated with improvement in self-reported visual functioning among Mexican school-aged children. View Abstract
The association between refractive cutoffs for spectacle provision and visual improvement among school-aged children in South Africa. View Abstract
Factors associated with spectacle-wear compliance in school-aged Mexican children. View Abstract
Locations